Anti-Mesothelin [MB], Rabbit IgG, kappa
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format for improved compatibility with existing reagents assays and techniques. |
Anti-CD28 [9.3], Rabbit IgG, kappa
| Applications | Bl, ELISA, IF, IP |
| Reactivities | Human |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format for improved compatibility with existing reagents assays and techniques. |
Anti-Terminal Deoxynucleotidyl Transferase [32D5], Rabbit IgG, kappa
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format for improved compatibility with existing reagents assays and techniques. |
Anti-MYOD1 [6F4-2D7], Rabbit IgG, kappa
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format for improved compatibility with existing reagents assays and techniques. |
Anti-CD3e [33H1], Rabbit IgG, kappa
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format for improved compatibility with existing reagents assays and techniques. |
Anti-Cytokeratin 20 [10A2], Rabbit IgG, kappa
| Applications | ELISA, IHC, WB |
| Reactivities | Human |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format for improved compatibility with existing reagents assays and techniques. |
Anti-CD4 [OX-38], Rabbit IgG, kappa
| Applications | FC, IP |
| Reactivities | Rat |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format for improved compatibility with existing reagents assays and techniques. |
United States
Germany
Japan
United Kingdom
China